Strategic proposals to avoid drug interactions during drug development: a lesson from a terfenadine-related drug interaction.
Ishizaki
T
T
Department of Clinical Pharmacology, International Medical Center of Japan, Tokyo, Japan.
D015195:Drug Design; D004347:Drug Interactions; D006801:Humans; D007654:Ketoconazole / Q000009:adverse effects*; D018570:Risk Assessment; D016593:Terfenadine / Q000009:adverse effects*; D016171:Torsades de Pointes / Q000139:chemically induced
D016593:Terfenadine; D007654:Ketoconazole